Important ad hoc analysis of JCOG 0802 for local recurrence, suggested by Elliot Servais

Elliot Servais, Associate Professor of Surgery, UMass Chan Medical School, Tufts University School of Medicine, shared a post by Stephen V Liu on X, adding:

“Very important ad hoc analysis of JCOG 0802 for local recurrence. LR matters to patients! LR means additional invasive diagnostic & therapeutic procedures and anxiety.

Critical to incorporate these data into patient-centric, individualized NSCLC treatment plans.”

Quoting Stephen V Liu:

“Analysis of locoregional relapse after segmentectomy in JCOG0802 JTO & JTO CRR. Multivariable analysis associates pure-solid on thin-section CT (OR 3.23), margin < tumor size (OR 2.68), & male sex (OR 2.09) with LR.

Trend in left lingular segment site.”

Risk factors for locoregional relapse after segmentectomy: Supplementary analysis of the JCOG0802/WJOG4607L trial

Authors: Kazuo Nakagawa, et al.

Stephen V Liu is an Associate Professor of Medicine at Georgetown University, where he holds the positions of Director of Thoracic Oncology and Head of Developmental Therapeutics at the Georgetown Lombardi Comprehensive Cancer Center. As a board-certified medical oncologist specializing in lung cancer and drug development, Dr. Liu is known for his expertise in advanced thoracic malignancies. His research focuses on novel therapeutic agents and innovative combinations to improve treatment outcomes for patients with lung cancer. Dr. Liu has received multiple teaching awards and actively engages in post-graduate education initiatives. Furthermore, he co-hosts the official podcast of the International Association for the Study of Lung Cancer (IASLC), “Lung Cancer Considered”.